For example, niches may be created by addressing specific unmet needs in certain patient types (e.g., patients who prefer not to inject, or who failed prior lines of GLP-1s), or by addressing specific access issues (e.g., developing a lower-cost option, securing broader payer coverage)
Metabolism2000 Jun;49(6):709-17
Cell 174 , 13471360 (2018)
Env Health Perspect 116:898906 Delfino RJ, Staimer N, Tjoa T, Gillen D, Polidori A, Arhami M, Kleinman MT, Vaziri N, Longhurst J, Sioutas C (2009) Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms